Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXN PR in moderate to severe idiopathic RLS
NCT01112644Phase 3Completed
- Sponsor
- Mundipharma
- Start
- Apr 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of oxycodone + naloxone in restless legs syndrome (RLS), sponsored by Mundipharma. Started Apr 2010; status: completed.
02
Drugs
oxycodone + naloxone
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT01112644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01112644.